Search - tctmd.com

Displaying 41 - 60 of 308

Sort: Relevancy | Date

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

News Conference News NY Valves 2024

National Data Point to Soaring TAVI Rates in Patients Under 65

Michael O'Riordan

June 14, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2024

Shelley Wood

April 03, 2024

News Daily News

FDA Approves TriClip TEER Device for Tricuspid Repair

L.A. McKeown

April 02, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

News Daily News

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Michael O'Riordan

March 15, 2024

News Daily News

Occupational Hazard? CTO Cases Drive Up Operators’ BP, Heart Rates

Yael L. Maxwell

March 11, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2024

Shelley Wood

March 01, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

TAVI Proficiency Doesn’t Spell Success for M-TEER at Large US Sites

Michael O'Riordan

February 13, 2024

News Daily News

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

Michael O'Riordan

February 09, 2024

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

L.A. McKeown

February 02, 2024

News Conference News STS 2024

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Yael L. Maxwell

February 01, 2024

News Daily News

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Michael O'Riordan

January 25, 2024

Advertisement

July 2024 Dispatch for the CV Team

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

National Data Point to Soaring TAVI Rates in Patients Under 65

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

May 2024 Dispatch for the CV Team

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

TCTMD’s Top 10 Most Popular Stories for March 2024

FDA Approves TriClip TEER Device for Tricuspid Repair

Evoque and Patisiran: A Tale of Two Regulatory Journeys

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Occupational Hazard? CTO Cases Drive Up Operators’ BP, Heart Rates

Debating the Role of T-TEER in the Sickest Patients

TCTMD’s Top 10 Most Popular Stories for February 2024

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

TAVI Proficiency Doesn’t Spell Success for M-TEER at Large US Sites

FDA Advisors Set to Take on TriClip for TR as TRILUMINATE Questions Loom

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content